Atlas Trials

Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India

Clinical trial NCT03070704 · WITHDRAWN

Trial details

NCT number
NCT03070704
Sponsor
Novo Nordisk A/S
Status
WITHDRAWN
Study type
OBSERVATIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2017-08-16
Primary completion
2019-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.